Advancing Radiotherapy for Bladder Cancer: Randomised Phase II Trial of Adaptive Image-guided Standard or Dose-escalated Tumour Boost Radiotherapy (RAIDER)

Clinical Oncology ◽

10.1016/j.clon.2021.02.012 ◽

2021 ◽

Author(s):

S. Hafeez ◽

R. Lewis ◽

E. Hall ◽

R. Huddart ◽

A. Birtle ◽

...

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Image Guided ◽

Boost Radiotherapy

Download Full-text

Final results from a national multicenter phase II trial of combination bacillus Calmette-Guérin plus interferon α-2B for reducing recurrence of superficial bladder cancer☆

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2005.11.026 ◽

2006 ◽

Vol 24 (4) ◽

pp. 344-348 ◽

Author(s):

Fadi N. Joudi ◽

Brian J. Smith ◽

Michael A. O’Donnell

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Superficial Bladder Cancer ◽

Interferon Α ◽

Bacillus Calmette Guerin ◽

Multicenter Phase

Download Full-text

A phase II trial to evaluate single-dose stereotactic body radiation therapy (SBRT) prior to surgery for early-stage breast carcinoma: SIGNAL (stereotactic image-guided neoadjuvant ablative radiation then lumpectomy) trial

Journal of Radiation Oncology ◽

10.1007/s13566-015-0227-2 ◽

2015 ◽

Vol 4 (4) ◽

pp. 423-430 ◽

Author(s):

Keegan Guidolin ◽

Michael Lock ◽

Brian Yaremko ◽

Neil Gelman ◽

Stewart Gaede ◽

...

Keyword(s):

Radiation Therapy ◽

Single Dose ◽

Breast Carcinoma ◽

Phase Ii ◽

Stereotactic Body Radiation Therapy ◽

Phase Ii Trial ◽

Early Stage ◽

Stereotactic Body Radiation ◽

Download Full-text

Interim results from a national multicenter phase II trial of combination bacillus Calmette-Guerin plus interferon alfa-2b for superficial bladder cancer

Urologic Oncology Seminars and Original Investigations ◽

10.1016/j.urolonc.2005.03.010 ◽

2005 ◽

Vol 23 (3) ◽

pp. 218

Author(s):

William A. See

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Superficial Bladder Cancer ◽

Interferon Alfa ◽

Bacillus Calmette Guerin ◽

Multicenter Phase

Download Full-text

203 PRELIMINARY RESULTS OF A PHASE II TRIAL OF IRINOTECAN (I) AND GEMCITABINE (G) IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC BLADDER CANCER.

Journal of Investigative Medicine ◽

10.1136/jim-52-suppl1-756 ◽

2004 ◽

Vol 52 (Suppl 1) ◽

pp. S293.3-S293

Author(s):

U B Chaudhary ◽

S Shannon ◽

N Curry ◽

T E Keane ◽

R T Means

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Locally Advanced ◽

Preliminary Results ◽

Metastatic Bladder Cancer

Download Full-text

Re: Multicenter Prospective Phase II Trial of Neoadjuvant Dose-dense Gemcitabine Plus Cisplatin in Patients with Muscle-invasive Bladder Cancer

European Urology ◽

10.1016/j.eururo.2019.07.019 ◽

2019 ◽

Vol 76 (6) ◽

pp. 870-871

Author(s):

Charlotte S. Voskuilen ◽

Michiel S. van der Heijden ◽

Bas W.G. van Rhijn

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Invasive Bladder Cancer ◽

Muscle Invasive Bladder Cancer ◽

Prospective Phase ◽

Muscle Invasive ◽

Download Full-text

Surgical and Pathologic Outcomes in Patients on a Phase II Trial of Neoadjuvant Chemotherapy and Hypofractionated Image-Guided Intensity Modulated Radiation Therapy (HIGRT) in Resectable and Borderline Resectable Pancreatic Cancer

International Journal of Radiation Oncology*Biology*Physics ◽

10.1016/j.ijrobp.2018.07.056 ◽

2018 ◽

Vol 102 (3) ◽

pp. S180

Author(s):

S.J. Stephens ◽

B. Czito ◽

X. Zhang ◽

E. Duffy ◽

M. Malicki ◽

...

Keyword(s):

Pancreatic Cancer ◽

Radiation Therapy ◽

Neoadjuvant Chemotherapy ◽

Phase Ii ◽

Phase Ii Trial ◽

Intensity Modulated Radiation Therapy ◽

Resectable Pancreatic Cancer ◽

Borderline Resectable ◽

Image Guided ◽

Intensity Modulated

Download Full-text

Long-term outcomes of a phase II trial of moderate hypofractionated image-guided intensity modulated radiotherapy (IG-IMRT) for localized prostate cancer

Radiotherapy and Oncology ◽

10.1016/j.radonc.2016.10.017 ◽

2017 ◽

Vol 122 (1) ◽

pp. 93-98 ◽

Author(s):

Hester Lieng ◽

Melania Pintilie ◽

Andrew Bayley ◽

Alejandro Berlin ◽

Robert Bristow ◽

...

Keyword(s):

Prostate Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Intensity Modulated Radiotherapy ◽

Localized Prostate Cancer ◽

Long Term Outcomes ◽

Image Guided ◽

Intensity Modulated

Download Full-text

Preliminary results of phase II trial of concomitant administration of intra-vesical reduced dose Bacillus Calmette- Guerin (BCG) and interferon a 2B (IFN) in the prevention of recurrence of superficial bladder cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.14_suppl.4716 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4716-4716

Author(s):

S. Bazarbashi ◽

M. Raja ◽

S. Kattan ◽

M. Rahal ◽

A. El-Weshi ◽

...

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Superficial Bladder Cancer ◽

Concomitant Administration ◽

Bacillus Calmette Guerin ◽

Preliminary Results ◽

Reduced Dose ◽

Prevention Of Recurrence

Download Full-text

Preliminary results of phase II trial of concomitant administration of intra-vesical reduced dose Bacillus Calmette- Guerin (BCG) and interferon a 2B (IFN) in the prevention of recurrence of superficial bladder cancer

Journal of Clinical Oncology ◽

10.1200/jco.2004.22.90140.4716 ◽

2004 ◽

Vol 22 (14_suppl) ◽

pp. 4716-4716

Author(s):

S. Bazarbashi ◽

M. Raja ◽

S. Kattan ◽

M. Rahal ◽

A. El-Weshi ◽

...

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Phase Ii Trial ◽

Superficial Bladder Cancer ◽

Concomitant Administration ◽

Bacillus Calmette Guerin ◽

Preliminary Results ◽

Reduced Dose ◽

Prevention Of Recurrence

Download Full-text

Phase II trial of paclitaxel/cisplatinum concomitant with adjuvant radiotherapy for treatment of bladder cancer.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.e15084 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. e15084-e15084

Author(s):

W. O. Arafat ◽

A. Darwish ◽

W. Sameh ◽

G. Elhossiny

Keyword(s):

Bladder Cancer ◽

Phase Ii ◽

Adjuvant Radiotherapy ◽

Download Full-text